93

General objective Specific objective Policy actions Adoption of a regulation on the acquisition of marine genetic resources in ABNJ Setting out best practice guidance on ABS issues at Member State level Identify good practices and information exchange Supporting the implementation of Nagoya protocol through the continued development of model ABS agreements and appropriate support mechanisms. X X X Option 1 Option 2 Option 3 Option 4 X X X Below we describe the policy options as well as the policy actions which can be connected according to Table 4.2. We have bundled some policy actions in anticipation of the assessments of their impacts in the subsequent stage of the project. 4.7.1 Policy option 1: No additional action Option 1 is the baseline scenario and involves making no changes to the existing situation, in particular:  processes that are characteristic of the sector;     there will be no further guidance regarding the scope of the sector; there will be no further clarification of the distinction between industrial biotechnology and Blue Biotechnology; and current financing instruments such as Horizon 2020 will continue to be used to support (Blue) Biotechnology industry; and no financing and regulative instrument (directive, regulation etc.) specific to Blue Biotechnology will be introduced. 4.7.2 Policy option 2: Facilitating and promoting (soft policy measure) Option 2 involves facilitating and promoting a number of key issues with regard to the Blue Biotechnology sector and may include the following policy actions in line with the above specific objectives (SO = Specific objective referred to): A. Support the development of the Marine Biotechnology ERA-NET (ERA-MBT) (SO1); B. Promote collaboration between stakeholders via EU level and international workshops and other events (SO1); C. Mapping of Blue Biotechnology SMEs (in order to increase visibility - passively) (SO1 + SO3); the existing definition of the Blue Biotechnology sector will remain as per the recommendation from the OECD101 and there will be no clarification with regard to the specific applications and 101 The OECD definition uses the term of Marine Biotechnology and within this report we have worked with the assumption that Marine and Blue Biotechnology are describing the same industry, for the definition please see the following link http://stats.oecd.org/glossary/detail.asp?ID=219 68 Study in support of Impact Assessment work on Blue Biotechnology

94 Publizr Home


You need flash player to view this online publication